---
title: "CV"
---

> **Zheran Liu (刘哲然)**  
> Postdoctoral Researcher & Physician, Cancer Center, **West China Hospital (Sichuan University)**  
> Email: <mailto:zeno.liu@outlook.com>  
> ORCID: <https://orcid.org/0000-0002-4848-4951>  
> PubMed: <https://pubmed.ncbi.nlm.nih.gov/?term=Liu+Zheran%5BAuthor%5D>

## Education

- **PhD/MSc (Oncology; MD–PhD track)** — West China School of Medicine / West China Hospital, Sichuan University, China (2019.09–2025.06)
  - China Association for Science and Technology (CAST) **Young Talent Support Program** (PhD track)
  - Supervisor: Prof. Xingchen Peng
  - Honors/Scholarships (selected): National Scholarship (MOE, China); Abbott Medical Nutrition Scholarship; Daiichi Sankyo Scholarship; Outstanding Graduate Student; Outstanding Graduate

- **BMed (Clinical Medicine) + Sino‑UK Joint Program (Clinical Medicine & Biomedical Sciences)** — Nanchang University, China (2014.09–2019.06)
  - Dual-degree track (Nanchang University × Queen Mary University of London)
  - CET‑6: 552

## Appointments

- **Postdoctoral Researcher & Physician** — Cancer Center, West China Hospital (Sichuan University), China (2025.07–present)

## Research interests

- Oncology and cancer bioinformatics
- Sequencing / multi‑omics analysis (bulk & single‑cell)
- Translational research and clinical data integration

## Publications (summary)

> Updated automatically from OpenAlex using ORCID (**0000-0002-4848-4951**) on 2026‑02‑04.

- Total publications (OpenAlex matched): **157**
- H‑index (computed from OpenAlex cited_by_count): **14**
- Total citations (OpenAlex): **775**

> Note: counts can differ from Google Scholar/PubMed due to author disambiguation and indexing coverage.

## Representative publications (first / co‑first)

1. **Liu Z**. *Liquid–liquid phase separation: roles and implications in future cancer treatment.* **Int J Biol Sci**. 2023;19(13):4139–4156. doi:10.7150/ijbs.81521
2. **Liu Z**. *Association between fish oil supplementation and cancer risk according to fatty fish consumption: a large prospective cohort study using UK Biobank.* **Int J Cancer**. 2022;150(4):562–571.
3. **Liu Z**. *Associations of sleep and circadian phenotypes with COVID‑19 susceptibility and hospitalization: UK Biobank observational cohort + two‑sample Mendelian randomization.* **Sleep**. 2022;45(6):zsac003.
4. Zhao Y, **Liu Z**. *Biomimetic Hierarchical Construction of Anti‑Tumor Polyoxopalladates for Cancer Therapy.* **Angew Chem Int Ed**. 2025;64(23):e202505564.

> Full list: see PubMed link above.

## Patents (filed; selected)

- Use of mesenchymal stem cell–derived exosomes for treating radiation‑induced skin injury (202410662238.4)
- Radioresistant head and neck squamous cell carcinoma cell line: construction and applications (202410790223.6)
- Radioresistant mouse oral squamous cell carcinoma cell line: construction and applications (202410790222.1)
- Use of SPOP protein for hepatocellular carcinoma therapeutics (202410892129.1)

## Grants & projects

- **PI** — Sichuan Provincial Department of Science and Technology, MZGC20230020: Prognostic model for brain metastasis based on hematological markers (2023‑06‑01 to 2024‑06‑01), 20,000 RMB
- **Key participant (lead analyst)** — Central Government‑Guided Local S&T Development, 2024ZYD0054: CAF‑mediated EGFR‑TKI resistance in HNSCC (2024‑09‑01 to 2025‑08‑31), 300,000 RMB
- **Key participant (lead analyst)** — Sichuan International/HK/Macao/Taiwan S&T Collaboration, 2025YFHZ0087: AI‑driven neoantigen prediction & mRNA vaccine development for HNSCC (2025‑01‑01 to 2025‑12‑31), 200,000 RMB
- **Participant** — National Key R&D Program of China, 2021YFE0206600: EBV‑targeted mRNA vaccine for nasopharyngeal carcinoma, 1,600,000 RMB (ongoing)

## Academic services

- Editorial Board Member: **BMC Cancer**
- Guest Editor: **Frontiers in Immunology**
- Reviewer: **The BMJ**, **iMeta**
- Memberships: **AACR**, Chinese Anti‑Cancer Association
- Committee roles (selected): Sichuan Medical Communication Society (Cancer Prevention & Control Branch); Chengdu Anti‑Cancer Association (Cancer Rehabilitation)

## Training & international experience

- ASCO Annual Meeting (Chicago), Poster (2024; No. 6046)
- AACR Annual Meeting (Orlando), Poster (2023; No. 5562)
- Harvard & Johns Hopkins Medical School Graduate Training Program (2020)
- Queen Mary University of London, Summer exchange (2016)

## Skills

- **Bioinformatics / data analysis**: extensive experience in single‑cell and transcriptomics analysis; clinical research statistics; data mining and visualization in **R**
- **Research**: end‑to‑end experience across basic, translational, and clinical oncology research
- **Grant writing / project operations**: protocol writing, project registration & submission, statistical analysis

## Licenses & certifications

- Physician License (China)
- GCP Certification
